Zoetis to sell medicated feed additive portfolio to Phibro


Zoetis and Phibro Animal Health announced that they have entered into an agreement where Phibro will acquire Zoetis’ medicated feed additive product portfolio, certain water-soluble products, and related assets for USD 350 million. This transaction is expected to be complete in H2 2024. The product...

Sign in  as a member, or Join our Community  for free to unlock the full article.